Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MeVis Medical Solutions AGFRA:M3V 66 ROC (Joel Greenblatt) % is 11.94% as of Mar. 2026, which is 100% below its 10-year median of 2,783.41. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.72. The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 97.9% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. MeVis Medical Solutions AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 11.94%.
The historical rank and industry rank for MeVis Medical Solutions AG's ROC (Joel Greenblatt) % or its related term are showing as below:
FRA:M3V'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 542.29 Med: 2783.41 Max: 5549.3
Current: 542.29
During the past 13 years, MeVis Medical Solutions AG's highest ROC (Joel Greenblatt) % was 5549.30%. The lowest was 542.29%. And the median was 2783.41%.
FRA:M3V's ROC (Joel Greenblatt) % is ranked better than 97.9% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 12.47
vs FRA:M3V: 542.29
MeVis Medical Solutions AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -16.40% per year.
MeVis Medical Solutions AG (FRA:M3V) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG ROC (Joel Greenblatt) % Chart
FRA:M3V vs VEEV, BTSG, TEM: ROC (Joel Greenblatt) % Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's ROC (Joel Greenblatt) % falls into.
MeVis Medical Solutions AG ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 11.94% mean?
MeVis Medical Solutions AG (FRA:M3V) has a ROC (Joel Greenblatt) % of 11.94% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on MeVis Medical Solutions AG and its competitors. This is 100% below median its historical median of 2,783.41. Over the past decade, MeVis Medical Solutions AG's ROC (Joel Greenblatt) % has ranged from 542.29 to 5,549.30. According to the industry distribution chart, MeVis Medical Solutions AG ranks #14 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 2.1%.
Is MeVis Medical Solutions AG's ROC (Joel Greenblatt) % too high?
MeVis Medical Solutions AG's current ROC (Joel Greenblatt) % of 11.94% is 100% below median its 10-year median of 2,783.41. Over the past 10 years, this metric has ranged from a low of 542.29 to a high of 5,549.30. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.47. MeVis Medical Solutions AG's value of 11.94% is 4.3% below this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #14 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's ROC (Joel Greenblatt) % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #14 out of 666 companies for ROC (Joel Greenblatt) %. This places MeVis Medical Solutions AG in the top 2% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.47. MeVis Medical Solutions AG's value of 11.94% is 4.3% below this benchmark. Historically, MeVis Medical Solutions AG's own ROC (Joel Greenblatt) % has ranged from 542.29 to 5,549.30 over the past decade. While the company's 10-year median is 2,783.41 vs. the industry median of 12.47, MeVis Medical Solutions AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current ROC (Joel Greenblatt) % of 11.94% is 4.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current ROC (Joel Greenblatt) % is 11.94%, which is 100% below median its own 10-year median of 2,783.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current ROC (Joel Greenblatt) % of 11.94%. The stock's GF Value™ is €22.72, compared to a current price of €24.00 — trading 5.6% above its estimated fair value. The current ROC (Joel Greenblatt) % is 11.94%, which is 100% below median its 10-year median of 2,783.41 and 4.3% below the Healthcare Providers & Services industry median of 12.47. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current ROC (Joel Greenblatt) % is 11.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €24.00 is trading 5.6% above its estimated GF Value™ of €22.72.
Key valuation signals for FRA:M3V:
ROC (Joel Greenblatt) %: 11.94% (100% below median its 10-year median of 2,783.41)
GF Value™: €22.72 vs. price of €24.00 (5.6% above fair value)
Industry Position: 4.3% below the Healthcare Providers & Services median (#14 of 666)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
